{"id":"https://openalex.org/W1995648407","doi":"https://doi.org/10.1517/14656560903092197","title":"Candesartan: widening indications for this angiotensin II receptor blocker?","display_name":"Candesartan: widening indications for this angiotensin II receptor blocker?","alternate_titles":[],"publication_year":2009,"publication_date":"2009-06-30","ids":{"openalex":"https://openalex.org/W1995648407","doi":"https://doi.org/10.1517/14656560903092197","mag":"1995648407","pmid":"https://pubmed.ncbi.nlm.nih.gov/19563275"},"language":"en","primary_location":{"id":"doi:10.1517/14656560903092197","doi":"https://doi.org/10.1517/14656560903092197","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656560903092197","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995648407"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037925341","display_name":"Buddhike Mendis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B Mendis","raw_affiliation_strings":["Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG72UH, UK. buddmen@yahoo.com","Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG72UH, UK. buddmen@yahoo.com","institution_ids":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464","institution_ids":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113608662","display_name":"SR Page","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"SR Page","raw_affiliation_strings":["Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464; +44 115 9701080; buddmen@yahoo.com","Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464; +44 115 9701080; buddmen@yahoo.com","institution_ids":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]},{"raw_affiliation_string":"Nottingham University Hospitals NHS Trust, QMC Campus, Department of Diabetes and Endocrinology, Derby Road, Nottingham NG7 2UH, UK +44 115 9249924 ext 64464","institution_ids":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0988,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.10787172,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"10","issue":"12","first_page":"1995","last_page":"2007"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candesartan","display_name":"candesartan","score":0.8700000047683716},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9829999804496765},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system","display_name":"renin-angiotensin-aldosterone system","score":0.996999979019165},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.7710000276565552},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.8230000138282776},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.9925525188446045},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8849954605102539},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.7405067682266235},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.6901389360427856},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.5276029706001282},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5273600220680237},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5067184567451477},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.49950337409973145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4793977737426758},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2847987711429596},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.14885103702545166}],"mesh":[{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14656560903092197","doi":"https://doi.org/10.1517/14656560903092197","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656560903092197","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:19563275","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19563275","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W75251984","https://openalex.org/W102024128","https://openalex.org/W1535983901","https://openalex.org/W1561463821","https://openalex.org/W1677944652","https://openalex.org/W1696992419","https://openalex.org/W1967140460","https://openalex.org/W1972339327","https://openalex.org/W1979030376","https://openalex.org/W1979302951","https://openalex.org/W1986075932","https://openalex.org/W1987301616","https://openalex.org/W1988604278","https://openalex.org/W1996479763","https://openalex.org/W1997002994","https://openalex.org/W2002462866","https://openalex.org/W2003670762","https://openalex.org/W2005588489","https://openalex.org/W2008935865","https://openalex.org/W2014759828","https://openalex.org/W2015899437","https://openalex.org/W2027550108","https://openalex.org/W2034187979","https://openalex.org/W2036931155","https://openalex.org/W2042164338","https://openalex.org/W2044773944","https://openalex.org/W2048359273","https://openalex.org/W2056976690","https://openalex.org/W2060106149","https://openalex.org/W2060890771","https://openalex.org/W2078751569","https://openalex.org/W2079039027","https://openalex.org/W2083444947","https://openalex.org/W2084343172","https://openalex.org/W2086199925","https://openalex.org/W2087285082","https://openalex.org/W2097433411","https://openalex.org/W2097546089","https://openalex.org/W2098780362","https://openalex.org/W2100409734","https://openalex.org/W2109689720","https://openalex.org/W2113671760","https://openalex.org/W2117556875","https://openalex.org/W2120294503","https://openalex.org/W2122264326","https://openalex.org/W2122624210","https://openalex.org/W2131467892","https://openalex.org/W2132697533","https://openalex.org/W2135038122","https://openalex.org/W2136115956","https://openalex.org/W2137561245","https://openalex.org/W2140172772","https://openalex.org/W2141003394","https://openalex.org/W2142630332","https://openalex.org/W2143954917","https://openalex.org/W2144042768","https://openalex.org/W2147918774","https://openalex.org/W2151865548","https://openalex.org/W2152798629","https://openalex.org/W2153769155","https://openalex.org/W2156850243","https://openalex.org/W2157382533","https://openalex.org/W2159854507","https://openalex.org/W2160162189","https://openalex.org/W2161392015","https://openalex.org/W2162963211","https://openalex.org/W2167964651","https://openalex.org/W2168663060","https://openalex.org/W2204156286","https://openalex.org/W2318940751","https://openalex.org/W2409137581","https://openalex.org/W2418674838","https://openalex.org/W2433953280","https://openalex.org/W2590382859","https://openalex.org/W2615684303","https://openalex.org/W3021250193","https://openalex.org/W3211853851","https://openalex.org/W4230893588","https://openalex.org/W4237370726","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2076496573","https://openalex.org/W2171853698","https://openalex.org/W2041947925","https://openalex.org/W1998358424","https://openalex.org/W2127848688","https://openalex.org/W2883459597","https://openalex.org/W2095316629","https://openalex.org/W2104634060","https://openalex.org/W2903008555","https://openalex.org/W1967778560"],"abstract_inverted_index":{"Candesartan":[0,75],"cilexetil":[1],"is":[2,76],"one":[3],"of":[4,7,9,20,25,36,57,71,97,113,127,132,145],"a":[5,77],"number":[6],"drugs":[8,147],"the":[10,26,34,37,55,67,95,111,125,130,140,143],"angiotensin":[11,27,83],"II":[12,28,41,84],"receptor":[13,42,87],"blocker":[14,43],"(ARB)":[15],"class.":[16],"Their":[17],"principal":[18],"mode":[19],"action":[21],"involves":[22],"competitive":[23],"blockade":[24],"type":[29,85],"1":[30,86],"receptor,":[31],"thereby":[32],"modulating":[33],"activity":[35],"rennin-angiotensin-aldosterone":[38],"system.":[39],"Angiotensin":[40],"therapy":[44],"has":[45,101],"been":[46],"proven":[47],"to":[48],"be":[49],"well":[50],"tolerated":[51],"and":[52,66,69,81,120],"effective":[53],"in":[54,92,110,123,148],"management":[56],"hypertension,":[58],"chronic":[59],"heart":[60,115],"failure":[61],"with":[62,104],"left":[63],"ventricular":[64],"dysfunction":[65],"prevention":[68],"progression":[70,131],"diabetic":[72,117,133],"renal":[73,118],"disease.":[74],"highly":[78],"potent,":[79],"long-acting":[80],"selective":[82],"blocker.":[88],"It":[89],"was":[90],"launched":[91],"1998":[93],"for":[94],"treatment":[96,112],"hypertension.":[98],"Its":[99],"use":[100,144],"increased":[102],"dramatically,":[103],"recently":[105,122],"published":[106],"data":[107],"suggesting":[108],"benefit":[109],"stroke,":[114],"failure,":[116],"disease":[119],"most":[121],"preventing":[124],"development":[126],"or":[128],"delaying":[129],"retinopathy.":[134],"In":[135],"this":[136],"article":[137],"we":[138],"review":[139],"literature":[141],"on":[142,152],"ARB":[146],"general":[149],"before":[150],"focusing":[151],"candesartan.":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995648407","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
